The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields
Open accessAbstract
The use of stents for vascular disease has resulted in a paradigm shift with significant improvement in therapeutic outcomes. Polymer-coated drug-eluting stents (DES) have also significantly reduced the incidence of reobstruction post stenting, a disorder termed in-stent restenosis. However, the current DESs lack the capacity for adjustment of the drug dose and release kinetics to the disease status of the treated vessel. We hypothesized that these limitations can be addressed by a strategy combining magnetic targeting via a uniform field-induced magnetization effect and a biocompatible magnetic nanoparticle (MNP) formulation designed for efficient entrapment and delivery of paclitaxel (PTX). Magnetic treatment of cultured arterial smooth muscle cells with PTX-loaded MNPs caused significant cell growth inhibition, which was not observed under nonmagnetic conditions. In agreement with the results of mathematical modeling, significantly higher localization rates of locally delivered MNPs to stented arteries were achieved with uniform-field–controlled targeting compared to nonmagnetic controls in the rat carotid stenting model. The arterial tissue levels of stent-targeted MNPs remained 4- to 10-fold higher in magnetically treated animals vs. control over 5 days post delivery. The enhanced retention of MNPs at target sites due to the uniform field-induced magnetization effect resulted in a significant inhibition of in-stent restenosis with a relatively low dose of MNP-encapsulated PTX (7.5 μg PTX/stent). Thus, this study demonstrates the feasibility of site-specific drug delivery to implanted magnetizable stents by uniform field-controlled targeting of MNPs with efficacy for in-stent restenosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a follow-up study using the same experimental setup, the group used magnetic nanoparticles loaded with paclitaxel for local delivery, and they observed a substantial reduction in restenosis with low doses of paclitaxel103.”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [103]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peters, T. (1985) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60065-0 · Cited by 2,196
Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden
Lagerqvist, B., James, S. K., Stenestrand, U., Lindbäck, J., Nilsson, T., & Wallentin, L. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067722 · Cited by 1,197
Colombo, A., Drzewiecki, J., BANNING, A. P., Grube, E., Hauptmann, K. E., Silber, S., Dudek, D., Fort, S., Schiele, F., Zmudka, K., et al. (2003) · Circulation · doi:10.1161/01.cir.0000086926.62288.a6 · Cited by 1,015
Microencapsulation : methods and industrial applications
Benita, S. (1996) · Medical Entomology and Zoology · Cited by 811
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy
Kim, S. C., Kim, D. W., Shim, Y. H., Bang, J. S., Oh, H. S., Kim, S. W., & Seo, M. H. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00275-9 · Cited by 734
Duda, S. H., Bosiers, M., Lämmer, J., Scheinert, D., Zeller, T., Oliva, V. L., Tielbeek, A. V., Anderson, J., Wiesinger, B., Tepe, G., et al. (2006) · Journal of Endovascular Therapy · doi:10.1583/05-1704.1 · Cited by 488
Preparation of Ultrafine Fe3O4Particles by Precipitation in the Presence of PVA at High pH
Lee, J., Isobe, T., & Senna, M. (1996) · Journal of Colloid and Interface Science · doi:10.1006/jcis.1996.0062 · Cited by 425
Duda, S. H., Bosiers, M., Lämmer, J., Scheinert, D., Zeller, T., Tielbeek, A. V., Anderson, J., Wiesinger, B., Tepe, G., Lansky, A. J., et al. (2005) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000151260.74519.ca · Cited by 405
Drug release from microdisperse systems: a critical review
Washington, C. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90280-h · Cited by 315
Moghimi, S. M., Porter, C. J. H., Muir, I. S., Illum, L., & Davis, S. S. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91869-e · Cited by 283
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–197 of 197
Nanomedicine’s promising therapy: magnetic drug targeting
Kempe, H., Kates, S. A., & Kempe, M. (2011) · Expert Review of Medical Devices · doi:10.1586/erd.10.94 · Cited by 23
Nano-engineering nanomedicines with customized functions for tumor treatment applications
Wang, Y., Li, S., Ren, X., Yu, S., & Meng, X. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01975-3 · Cited by 25
“can be 4–10 times higher than that of the non-magnetic control group [141].”
BackgroundHewlin, R. L., Smith, M., & Kizito, J. P. (2023) · Cardiovascular Engineering and Technology · doi:10.1007/s13239-023-00681-3 · Cited by 22
“…applied magnetic field intensity at the center of the parcel, χ mp is the magnetic susceptibility, µ 0 (4π × 10 -7 N·A -2 ) is the permeability in air [52, 53], and µ r is the relative permeability of the stent material which is 304 grade stainless steel with a relative permeability of 1.8 [34].”
BackgroundResultInfluentialTengood, J. E., Alferiev, I. S., Zhang, K., Fishbein, I., Levy, R. J., & Chorny, M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324104111 · Cited by 22
“Composite PLA-based magnetic particles were chosen as a model biodegradable NP formulation for evaluation in the present studies because of their rapid and quantitative, magnetically controlled cell uptake (17), facilitating and synchronizing measurements of the internalized MNP disassembly in cultured cells, and also…”
MethodSelf-citationNanoprobes and Their Applications in Veterinary Medicine and Animal Health
Sekh, B. S. (2012) · Research Journal of Nanoscience and Nanotechnology · doi:10.3923/rjnn.2012.1.16 · Cited by 22
Monolithically integrated Helmholtz coils by 3-dimensional printing
Li, L., Abedini‐Nassab, R., & Yellen, B. B. (2014) · Applied Physics Letters · doi:10.1063/1.4885441 · Cited by 21
Self-citationIn Situ Generated Medical Devices
Cohn, D., Sloutski, A., Elyashiv, A., Varma, V. B., & Ramanujan, R. V. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801066 · Cited by 20
Nanotechnology in interventional cardiology
Cyrus, T., Wickline, S. A., & Lanza, G. M. (2011) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.154 · Cited by 22
Uthamaraj, S., Tefft, B. J., Klabusay, M., Hlinomaz, O., Sandhu, G. S., & Dragomir‐Daescu, D. (2014) · Annals of Biomedical Engineering · doi:10.1007/s10439-014-1088-3 · Cited by 21
Delivery of Polymeric Nanoparticles to Target Vascular Diseases
Agyare, E., & Kandimalla, K. K. (2014) · Journal of Biomolecular Research & Therapeutics · doi:10.4172/2167-7956.s1-001 · Cited by 20
“Recent work published by Chorny and coworkers have also shown that iron oxide nanoparticles and paclitaxel entrapped within polylactide nanoparticles and directed by an induced magnetic field revealed a better diagnosis and sustained-release of antiproliferative to a pathological carotid artery site in animal model [9…”
BackgroundFellows, B. D., Ghobrial, N., Mappus, E., Hargett, A., Bolding, M., Dean, D. M. D., & Mefford, O. T. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.02.011 · Cited by 20
Nanoparticle-Mediated Cell Capture Enables Rapid Endothelialization of a Novel Bare Metal Stent
Tefft, B. J., Uthamaraj, S., Harbuzariu, A., Harburn, J. J., Witt, T. A., Newman, B., Psaltis, P. J., Hlinomaz, O., Holmes, D. R., Gulati, R., et al. (2018) · Tissue Engineering Part A · doi:10.1089/ten.tea.2017.0404 · Cited by 20
Sun, X., Liu, M., Chen, X., Lin, H., Liu, B., Peng, Y., Zhang, L., Shen, J., & Zhao, P. (2019) · Journal of Luminescence · doi:10.1016/j.jlumin.2019.02.019 · Cited by 19
Stimuli-responsive nanomaterials for cancer treatment: boundaries, opportunities and applications
Lafuente‐Gómez, N., Latorre, A., Milán-Rois, P., Rodríguez-Díaz, C., & Somoza, Á. (2021) · Chemical Communications · doi:10.1039/d1cc05056g · Cited by 19
Adjei, I. M., Yang, H., Plumton, G., Maldonado-Camargo, L., Dobson, J., Rinaldi, C., Jiang, H., & Sharma, B. (2019) · Drug Delivery and Translational Research · doi:10.1007/s13346-019-00621-6 · Cited by 18
MacDonald, C., Barbee, K., & Polyak, B. (2012) · Pharmaceutical Research · doi:10.1007/s11095-011-0663-7 · Cited by 17
“Previous work has shown that MNPs and MNP-loaded endothelial cells are promising vectors for targeted delivery to cardiovascular stents (17,24,25).”
BackgroundBiomaterial-Targeted Precision Nanoparticle Delivery to the Injured Spinal Cord
Ciciriello, A. J., Surnar, B., Medy, G. D., Su, X., Dhar, S., & Dumont, C. M. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.08.077 · Cited by 16
Zhai, Y., Zhang, H., Zhang, L., & Dong, S. (2016) · Nanoscale · doi:10.1039/c6nr00948d · Cited by 16
A concise review on bio-responsive polymers in targeted drug delivery system
Karati, D. (2022) · Polymer Bulletin · doi:10.1007/s00289-022-04424-7 · Cited by 15
“In vitro experiments have shown comparatively low dose inhibition of cell growth and brief (five minute) magnetic field exposure [64]”
BackgroundPath-Dependent Self-Assembly of Magnetic Anisotropic Colloidal Peanuts
Kamal, M. A., Petukhov, A. V., & Pal, A. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c03771 · Cited by 15
Magnetic nanoparticles research: a scientometric analysis of development trends and research fronts
Liu, P., Chen, B., Liu, K., & Xie, H. (2016) · Scientometrics · doi:10.1007/s11192-016-2017-z · Cited by 14
“2008) and ‘Chorny2010’ (Chorny et al. 2010) are with the highest centrality.”
Magnetic Cell Targeting for Cardiovascular Tissue Engineering
Shradhanjali, A., Wolfe, J. T., & Tefft, B. J. (2024) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2024.0103 · Cited by 13
“2,23 25 – 27 Such applications may require a high dose of magnetic nanoparticles that results in unacceptable cytotoxicity.”
Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention
Uthamaraj, S., Tefft, B. J., Hlinomaz, O., Sandhu, G. S., & Dragomir‐Daescu, D. (2015) · Journal of Visualized Experiments · doi:10.3791/53100 · Cited by 12
Next-Generation Nanoantibacterial Tools Developed from Peptides
de Vries, R. J., Andrade, C. A., Bakuzis, A. F., Mandal, S. M., & Franco, O. L. (2015) · Nanomedicine · doi:10.2217/nnm.15.9 · Cited by 12
Tateiwa, D., Kaito, T., Hashimoto, K., Okada, R., Kodama, J., Kushioka, J., Bal, Z., Tsukazaki, H., Nakagawa, S., Ukon, Y., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.802699 · Cited by 12
“Retinoid-loaded NPs were formulated using a modification of the emulsificationsolvent evaporation method with albumin as a colloidal stabilizer (Chorny et al., 2010; Chorny et al., 2012).”
MethodSelf-citationChorny, M., Fishbein, I., Adamo, R. F., Forbes, S. P., Folchman-Wagner, Z., & Alferiev, I. S. (2012) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-8-1-23 · Cited by 12
“14, 15 Magnetic targeting is a physical approach that, like other physical strategies such as ultrasound-assisted drug delivery and brachytherapy, is designed to selectively deliver therapy to spatially defined targets. in this respect, physical targeting methods are distinct from approaches where…”
Self-citationNanofluids Long-term Stability Challenges and Guidelines
Chakraborty, S., Kumar, P., & Chakraborty, S. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839166457-00071 · Cited by 11
Nanotheranostics: Nanoparticles Applications, Perspectives, and Challenges
Ojha, A. K., Rajasekaran, R., Pandey, A. K., Dutta, A., Seesala, V. S., Das, S. K., Chaudhury, K., & Dhara, S. (2021) · Springer eBooks · doi:10.1007/978-981-16-2782-8_14 · Cited by 10
Nanomedicine highlights in atherosclerosis
Karagkiozaki, V. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-1529-1 · Cited by 11
Purkait, M. K., Sinha, M. K., Mondal, P., & Singh, R. (2018) · Interface science and technology · doi:10.1016/b978-0-12-813961-5.00007-3 · Cited by 11
Zhang, H., Li, Y., Zhang, P., Ren, C., Xu, X., Sun, B., & Yang, Z. (2021) · IEEE Transactions on Components Packaging and Manufacturing Technology · doi:10.1109/tcpmt.2021.3082923 · Cited by 11
“[23] reported an approach to combine the medical stent and drug-loaded MNPs to adjust the targeted dose and drug release process.”
MethodVarshosaz, J., Javanmard, S. H., Soghrati, S., & Behdadfar, B. (2016) · RSC Advances · doi:10.1039/c5ra20966h · Cited by 11
Ng, J. C. K., Toong, D. W. Y., Ow, V., Chaw, S. Y., Toh, H. W., Wong, P. E. H., Venkatraman, S. S., Chong, T. T., Tan, L. P., Huang, Y., et al. (2022) · Nanomedicine · doi:10.2217/nnm-2021-0288 · Cited by 10
Fishbein, I., Forbes, S. P., Chorny, M., Connolly, J. M., Adamo, R. F., Corrales, R. A., Alferiev, I. S., & Levy, R. J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.05.047 · Cited by 10
“arteries as described in our previous publications [26,27,34,35].”
Self-citationSmart polymer composites in drug delivery
Shalla, A. H., & Bhat, M. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819961-9.00009-8 · Cited by 13
Cardiac regenerative medicine: At the crossroad of microRNA function and biotechnology
Raso, A., & Dirkx, E. (2017) · Non-coding RNA Research · doi:10.1016/j.ncrna.2017.03.001 · Cited by 9
Endovascular Gene Delivery from a Stent Platform: Gene- Eluting Stents
Adamo, M. C. R. F. (2013) · Angiology Open Access · doi:10.4172/2329-9495.1000109 · Cited by 9
“During and immediately after MNP/Ad-Luc delivery a uniform magnetic field of 0.1 Tesla was established across the neck area of the rats.”
BackgroundInfluentialSingh, N. K., Kulkarni, P. P., Tripathi, P., Agarwal, V., & Dash, D. (2024) · Nanoscale Advances · doi:10.1039/d3na00751k · Cited by 8
Multifunctional Magnetic Nanomedicine Drug Delivery and Imaging‐Based Diagnostic Systems
Aslam, H., Shukrullah, S., Naz, M. Y., Fatima, H., Ullah, S., & Al-Sehemi, A. G. (2021) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.202100179 · Cited by 8
Stimuli Responsive Carriers: Magnetically, Thermally and pH Assisted Drug Delivery
Muntimadugu, E., Jain, A., & Khan, W. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-11355-5_10 · Cited by 8
Magnetizable Duplex Steel Stents Enable Endothelial Cell Capture
Tefft, B. J., Gooden, J. Y., Uthamaraj, S., Harburn, J. J., Klabusay, M., Holmes, D. R., Simari, R. D., Dragomir‐Daescu, D., & Sandhu, G. S. (2012) · IEEE Transactions on Magnetics · doi:10.1109/tmag.2012.2224326 · Cited by 8
Cardiovascular Nanomedicine: A Posse Ad Esse
Godin, B., & Mauro Ferrari, B. (2012) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-8-1-2 · Cited by 8
“…thus clear considerations should be taken when developing a carrier for a specific drug or condition. the rational design of nanovectors for Cvd 12, 17 will be further discussed in this issue, as will the development of magnetically driven nanoparticles 18 and nanoparticles for blood pool imaging.”
Alferiev, I. S., Guerrero, D. T., Soberman, D., Guan, P. F., Nguyen, F., Kolla, V., Fishbein, I., Pressly, B. B., Brodeur, G. M., & Chorny, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031752 · Cited by 7
“Release kinetics were measured under perfect sink conditions using an external sink method [41,63].”
MethodSelf-citationEffect of particle size distribution on the magnetization of ferrofluid
Gharaibeh, M. A., Obeidat, A. A., Awawdeh, W. A., & Rousan, A. A. (2019) · Experimental and Theoretical NANOTECHNOLOGY · doi:10.56053/3.2.115 · Cited by 7
Therapeutic nanomaterials: from a drug delivery perspective
Kumar, C. G., Poornachandra, Y., & Sujitha, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46143-6.00001-4 · Cited by 9
Agrawal, A. A., Raval, A., Velhal, S., Patel, V. V., & Patravale, V. B. (2021) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2021-0245 · Cited by 7
Role of biomaterials in prevention of in‐stent restenosis
Laçin, N. T., & Utkan, G. (2013) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.33083 · Cited by 6
van der Merwe, J., & Casselman, F. P. A. (2023) · Journal of Visualized Surgery · doi:10.21037/jovs-22-40 · Cited by 5
A thermosensitive material coated resonant stent for drug delivery on demand
Bednar, V. B., & Takahata, K. (2021) · Biomedical Microdevices · doi:10.1007/s10544-021-00548-1 · Cited by 6
Methods for Magnetic Nanoparticle Synthesis and Functionalization
El‐Dakdouki, M. H., El‐Boubbou, K., Xia, J., Kavunja, H. W., & Huang, X. (2014) · doi:10.1002/9781118775882.ch10 · Cited by 6
Meng, X., Song, J., Meng, H., Liao, C., Yin, Z., Gong, K., Kong, D., Qi, J., & Duan, Y. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123482 · Cited by 5
ElSaygh, J., Zaher, A., Parikh, M. A., Frishman, W. H., & Peterson, S. J. (2024) · Cardiology in Review · doi:10.1097/crd.0000000000000727 · Cited by 6
“46 There are treatments available with nanotechnology to promote endothelialization.”
Powar, P. V. (2017) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2017v9i12.21544 · Cited by 5
Wireless Actuation of Micro/Nanorobots for Medical Applications
Tottori, S., Zhang, L., & Nelson, B. J. (2014) · Nanostructure science and technology · doi:10.1007/978-1-4614-2140-5_9 · Cited by 5
New insights to atherosclerosis management: Role of nanomaterials
Li, Z., Jiang, C. S., Chai, L., Fan, T., Li, C., Chen, Z., Huang, W., Zhang, B., Al‐Hartomy, O. A., Al‐Ghamdi, A. A., et al. (2022) · Applied Materials Today · doi:10.1016/j.apmt.2022.101466 · Cited by 5
Magnetic Nanoparticles: Novel Options for Vascular Repair?
Wenzel, D. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0031 · Cited by 5
Robust Chemical Strategy for Stably Labeling Polyester-Based Nanoparticles with BODIPY Fluorophores
Alferiev, I. S., Fishbein, I., Levy, R. J., & Chorny, M. (2022) · ACS Applied Polymer Materials · doi:10.1021/acsapm.1c01601 · Cited by 4
Self-citationBattig, M. R., Fishbein, I., Levy, R. J., Alferiev, I. S., Guerrero, D. T., & Chorny, M. (2017) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0412-5 · Cited by 4
“Our group has recently reported rapid and stable EC homing and expansion in stented arteries [31] achievable with two-source magnetic guidance, previously shown to be effective for site-specific vascular delivery of small-molecule drugs and gene vectors [32, 33].”
Self-citationNanocarrier Design for Dual-Targeted Therapy of In-Stent Restenosis
Alferiev, I. S., Zhang, K., Folchman-Wagner, Z., Adamo, R. F., Guerrero, D. T., Fishbein, I., Soberman, D., Levy, R. J., & Chorny, M. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020188 · Cited by 3
“As the stent configured in thin intersecting struts becomes magnetized, its geometry makes it highly efficient for guiding MNPs to the region of stent deployment by creating strong field gradients in its vicinity [1].”
BackgroundMethodInfluentialSelf-citationEffects of ferrohydrodynamics on drug transport and retention in drug eluting stents
Vahedi, S. M., & Azaiez, J. (2024) · Physics of Fluids · doi:10.1063/5.0203847 · Cited by 3
Quantitative real-time imaging of nanofluid convection–diffusion in the planar skin layer in vivo
Sung, B., Kim, M., Kim, M. S., Lee, J.-K., & Soh, K. (2017) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/aa5949 · Cited by 3
Tuning the Colloidal Crystal Structure of Magnetic Particles by External Field
Pal, A., Malik, V., He, L., Erné, B. H., Yin, Y., Kegel, W. K., & Petukhov, A. V. (2014) · Angewandte Chemie · doi:10.1002/ange.201409878 · Cited by 3
Drug Delivery Systems and Cardiovascular Disease
Wang, X., Liang, X., Duan, J., Chen, Y., Li, H., Liu, K., & Yang, J. (2024) · Springer eBooks · doi:10.1007/978-981-19-7712-1_4 · Cited by 2
New Technologies for Treatment of Coronary Artery Disease
Mojto, V. (2019) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2019.13.002411 · Cited by 2
“Other healing promoting agents are peptide amphiphilenanofiber coating, for promotion of endothelial cell adhesion and magnetic nanoparticles that cause preferential movement of cells towards the stent [7,11,24-27] (Figure 1).”
BackgroundLatha, S., Selvamani, P., Palanisamy, S. B., Raj, D. B. T. G., & Prabha, T. (2021) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-7998-5049-6.ch017 · Cited by 2
Tateiwa, D., Iwamoto, M., Kodama, J., Ukon, Y., Hirai, H., Ikuta, M., Kitahara, T., Furuichi, T., Bun, M., Otsuru, S., et al. (2023) · The Spine Journal · doi:10.1016/j.spinee.2023.11.021 · Cited by 2
Mohamad, E. A., Fikry, E. M., & Rageh, M. M. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04063-5 · Cited by 2
“Numerous enhanced magnetic nanoparticles have been created and used as innovative delivery systems to treat diseases, including cancer (Chorny et al. 2010a, b ; Zhou et al. 2007; Jenkins et al. 2011) and antibacterial effect (Mostafa et al. n.d.; Mohamad et al. n.d.).”
Autonomic Denervation Using Magnetic Nanoparticles
Fan, Y., Dormer, K. J., & Po, S. S. (2010) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2011.12.003 · Cited by 2
Site Specific Controlled Release for Cardiovascular Disease: Translational Directions
Fishbein, I., Chorny, M., Alferiev, I. S., & Levy, R. J. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0881-9_14 · Cited by 2
Self-citationCardiovascular Nanomedicine: Materials and Technologies
Gupta, A. S. (2015) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3121-7_13 · Cited by 2
Dimensional analysis of magnetophoresis
Heo, W., Hetts, S. W., & Rayz, V. L. (2023) · International Journal of Engineering Science · doi:10.1016/j.ijengsci.2023.103946 · Cited by 1
Xu, X., Liu, Q., Hu, Y., Li, H., Wang, Y., Sun, J., & Qin, K. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18070880 · Cited by 1
“Chorny et al. applied magnetic targeting by encapsulating paclitaxel into magnetic nanoparticles, which, under an external uniform magnetic field, facilitated localized accumulation at the stent and significantly enhanced drug retention at the injury site [119].”
Nanomedicine for Treatment of Cardiovascular Diseases and Stroke
Kumar, N., & Kumar, R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-323-26433-4.00005-1 · Cited by 1
Multifunctional Nanoscale Delivery Systems for Nucleic Acids
Conroy, R., & Seto, B. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4372-7_18 · Cited by 1
“gradient, such as implantable stents [122].”
Kharlamov, A. N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-50878-0.00023-9 · Cited by 1
Gene Delivery from Stents for Prevention of In-Stent Restenosis
Fishbein, I., Alferiev, I. S., Chorny, M., & Levy, R. J. (2016) · European Medical Journal · doi:10.33590/emj/10314517 · Cited by 1
Self-citationTripathi, S., Rani, K., Raj, V. S., & Ambasta, R. K. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.02.001 · Cited by 1
Varsani, R. R. (2014) · UWA Profiles and Research Repository (UWA)
Targeted delivery and MRI tracking of magnetically labelled cells
Riegler, J. (2012) · UCL Discovery (University College London)
Serbezov, V. S., Sotirov, S., & Serbezov, S. (2013) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2012006
Martínez-Banderas, A. I. (2016) · King Abdullah University of Science and Technology Repository (King Abdullah University of Science and Technology) · doi:10.25781/kaust-59671
Nanomedicines for Restenosis Therapy
Tengood, J. E., Fishbein, I., Levy, R. J., & Chorny, M. (2014) · Frontiers in nanobiomedical research · doi:10.1142/9789814520652_0019
Self-citationGene therapy for in-stent restenosis: Targets and delivery system
Yin, K., & Agrawal, D. K. (2014) · Current research. Cardiology · doi:10.4172/2368-0512.1000014
Battig, M. R., Alferiev, I. S., Guerrero, D. T., Fishbein, I., Pressly, B. B., Levy, R. J., & Chorny, M. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00466
Self-citationDarton, N. J., Ionescu, A., & Llandro, J. (2019) · Cambridge University Press eBooks · doi:10.1017/9781139381222.005
Jain, K. K. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6966-1_10
Vascular Disease: Drug Delivery Systems
Venkatraman, S. S., Keith, K., Rosen, Y., Huang, Y., Steele, T. W. J., & Alexis, F. (2016) · Taylor & Francis eBooks · doi:10.1081/e-ebpp-120052169
Nanomedicine research, development, and current clinical status
Babu, M. R., Rahaman, S. A., Venkateswarlu, G., Mishra, Y., & Mishra, V. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-90252-6.00002-5
Bioactive Compound-Loaded Nanocarriers for Treating Cardiovascular Diseases in Metabolic Disorders
Singh, V., Dutta, P., Sahoo, J., Prusty, S. K., Singh, S. P., & Tripathi, S. M. (2025) · Micro and Nanosystems · doi:10.2174/0118764029350668250520060953
i-Motifs in cancer diagnosis and treatment: fabrication and functionalization
Zamanian, J., Samie, A., Alavian, H., Alibolandi, M., Etemad, L., Abnous, K., & Taghdisi, S. M. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb01085c
Lin, D., Zhang, W., Xu, G., Tang, Y., Zhang, T., Zhang, W., Wu, Q., Xiong, D., Ma, R., & Wang, G. (2026) · Smart Materials in Manufacturing · doi:10.1016/j.smmf.2026.100142
Kitching, M., Kozlowska, D., Bashmail, R., Luca, M. D., & Cahill, P. A. (2026) · Vascular Pharmacology · doi:10.1016/j.vph.2026.107681
Heo, W., Hetts, S. W., & Rayz, V. L. (2026) · Bioengineering & Translational Medicine · doi:10.1002/btm2.70151
Effects of Extracellular Surface Interactions on Mass Transport across Epithelial Cells.
Min, K. A. (2013) · Deep Blue (University of Michigan)
Coronary Angioplasty and Drug-Eluting Stents
Jain, K. K. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-240-3_9
Microparticules magnetiques therapeutiques pour la chimio-embolisation ciblee du foie
Pouponneau, P. (2011) · PolyPublie (École Polytechnique de Montréal)
Metadata
- Authors
- Chorny, M., Fishbein, I., Yellen, B. B., Alferiev, I. S., Bakay, M., Ganta, S., Adamo, R., Amiji, M., Friedman, G., & Levy, R. J.
- Affiliations
- Children's Hospital of Philadelphia (US)
- Duke University (US)
- Northeastern University (US)
- Drexel University (US)
- Corresponding author
- Levy, Robert J.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-04-19
- Volume
- 107
- Issue
- 18
- Pages
- 8346-8351
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2889533
- OpenAlex
- W2154590970
- Cited by
- 197
- References
- 30
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 9 · 2023: 6 · 2022: 9 · 2021: 12 · 2020: 6 · 2019: 10 · 2018: 13 · 2017: 17 · 2016: 18 · 2015: 8 · 2014: 20 · 2013: 16 · 2012: 21
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- Children's Hospital of Philadelphia
- National Institutes of Health
- National Heart, Lung, and Blood Institute (T32HL007915)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Characterization and Applications of Magnetic Nanoparticles
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- drug-eluting stents, paclitaxel, magnetic nanoparticles, magnetic targeting, uniform magnetic field, in-stent restenosis, local drug delivery, arterial smooth muscle cells, carotid artery stenting, nanoparticle retention, vascular disease
- MeSH terms
- Animals, Cell Line, Graft Occlusion, Vascular, Magnetics, Male, Stents, Drug Delivery Systems, Rats, Sprague-Dawley, Paclitaxel, Microscopy, Electron, Transmission, Cell Proliferation, Rats, Metal Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
